Advertisement

Topics

Innovative Drug Delivery Platform Relies on Telos® Reagent Chips

06:07 EDT 13 Jun 2017 | Lab Bulletin

Telos® 2 Reagent Chips from Dolomite Microfluidics have helped San Francisco-based ProLynx LLC to develop a novel drug delivery platform.

Jeff Henise in the labJeff Henise, Director of Process Development at ProLynx, explained: “Traditional polymer encapsulation delivery systems rely on diffusion or breakdown of the polymer to release their payload. In contrast, our drug delivery system offers controlled release using self-cleaving linkers to attach the drug to hydrogel microsphere carriers....

Original Article: Innovative Drug Delivery Platform Relies on Telos® Reagent Chips

NEXT ARTICLE

More From BioPortfolio on "Innovative Drug Delivery Platform Relies on Telos® Reagent Chips"

Quick Search
Advertisement